Literature DB >> 7591552

The distribution of "big ticket" medical technologies in OECD countries. Organization for Economic Cooperation and Development.

P Lázaro1, K Fitch.   

Abstract

Five "big ticket" medical technologies (BTTs) in 1990 were compared in the 24 OECD countries in relation to population, the number of physicians, gross domestic product (GDP), and health care expenditures (HCE). Wide variations were observed between and within countries for all measures. Regression analysis revealed that HCE explains part of the variation in the distribution of computed tomography scanners (excluding Japan), magnetic resonance imaging units, and radiation therapy units (R2 between 0.40 and 0.69), but not extracorporeal shock wave lithotripters. To a lesser extent, GDP was also found to correlate with the distribution of these technologies, but no correlation was found with number of physicians. Other factors affecting the diffusion of these technologies are proposed for study.

Entities:  

Mesh:

Year:  1995        PMID: 7591552     DOI: 10.1017/s0266462300008722

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  3 in total

1.  The influence of economic incentives and regulatory factors on the adoption of treatment technologies: a case study of technologies used to treat heart attacks.

Authors:  Mickael Bech; Terkel Christiansen; Kelly Dunham; Jørgen Lauridsen; Carl Hampus Lyttkens; Kathryn McDonald; Alistair McGuire
Journal:  Health Econ       Date:  2009-10       Impact factor: 3.046

2.  The global diffusion of organ transplantation: trends, drivers and policy implications.

Authors:  Sarah L White; Richard Hirth; Beatriz Mahíllo; Beatriz Domínguez-Gil; Francis L Delmonico; Luc Noel; Jeremy Chapman; Rafael Matesanz; Mar Carmona; Marina Alvarez; Jose R Núñez; Alan Leichtman
Journal:  Bull World Health Organ       Date:  2014-08-22       Impact factor: 9.408

3.  Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK.

Authors:  Rucha Vadia; Tom Stargardt
Journal:  Appl Health Econ Health Policy       Date:  2020-09-24       Impact factor: 2.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.